| CXL20023024 | LY582563/MCC-478 | alamifovir | Active ingredient | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2003-07-07 | view |
| CXL20023025 | LY582563/MCC-478片 | alamifovir | Tablet | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2003-07-07 | view |
| CXL20023026 | LY582563/MCC-478片 | alamifovir | Tablet | Chemical Drugs(1) | New Drug Application | 2002-11-29 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Pending Approval | 2003-05-09 | view |
| CXS20020124 | 头孢克洛缓释片 | cefaclor | Tablet, extended release | Chemical Drugs(4) | New Drug Application | 2002-02-23 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2002-10-24 | view |
| CXSL2400415 | LY3540378注射液 | | Injection | Biological Products(1) | New Drug Application | 2024-06-27 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2500049 | 注射用LY4052031 | LY-4052031 | | Biological Products(1) | New Drug Application | 2025-01-16 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2500272 | 注射用LY4101174 | LY4101174 | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-08 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYHB0500927 | 头孢克洛胶囊 | cefaclor | Capsule | Chemical Drugs | Supplementary Application | 2005-08-04 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2005-11-23 | view |
| CYHB1103531 | 头孢克洛干混悬剂 | cefaclor | Suspension | Chemical Drugs | Supplementary Application | 2011-05-16 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2016-07-21 | view |
| CYSB2000047 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2020-03-21 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | In Review | 2020-03-20 | view |
| CYSB2000247 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-10-30 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2021-08-06 | view |
| CYSB2101210 | 人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2021-10-09 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2101244 | 精蛋白人胰岛素混合注射液（30R） | human insulin;isophane protamine human insulin | Injection | Biological Products | Supplementary Application | 2021-10-28 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2200013 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2022-01-13 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2200275 | 精蛋白锌重组赖脯胰岛素混合注射液（25R） | | Injection | Biological Products | Supplementary Application | 2022-12-13 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CYSB2500095 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2025-05-09 | | Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| J0300899 | 盐酸氟西汀胶囊 | fluoxetine hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2003-07-07 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd | Certificate Issued | 2003-11-27 | view |
| JXHB2000011 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Supplementary Application | 2020-08-25 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-08-24 | view |
| JXHB2000012 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Supplementary Application | 2020-08-25 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-08-24 | view |
| JXHB2000013 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Supplementary Application | 2020-08-25 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-08-24 | view |
